Literature DB >> 10625217

Synaptosomal response to oxidative stress: effect of vinpocetine.

M S Santos1, A I Duarte, P I Moreira, C R Oliveira.   

Abstract

It has been suggested that reactive oxygen species (ROS) play a role in the neuronal damage occurring in ischemic injury and neurodegenerative disorders and that their neutralization by antioxidant drugs may delay or minimize neurodegeneration. In the present study we examine whether vinpocetine can act as an antioxidant and prevent the formation of ROS and lipid peroxidation in rat brain synaptosomes. After ascorbate/Fe2+ treatment a significant increase in oxygen consumption (about 5-fold) and thiobarbituric acid reactive substances (TBARS) formation (about 7-fold) occurred as compared to control conditions. Vinpocetine inhibited the ascorbate/Fe2+ stimulated consumption of oxygen and TBARS accumulation, an indicator of lipid peroxidation, in a concentration-dependent manner. The ROS formation was also prevented by vinpocetine. Oxidative stress increased significantly the fluorescence of the probes 2',7'-dichlorodihydrofluorescein (DCFH2-DA) (about 6-fold) and dihydrorhodamine (DHR) 123 (about 10-fold), which is indicative of intrasynaptosomal ROS generation. Vinpocetine at 100 microM concentration decreased the fluorescence of DCFH2-DA and DHR 123 by about 50% and 83%, respectively. We conclude that the antioxidant effect of vinpocetine might contribute to the protective role exerted by the drug in reducing neuronal damage in pathological situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625217     DOI: 10.1080/10715760000300061

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  9 in total

1.  Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine.

Authors:  Omar M E Abdel-Salam; Yasser A Khadrawy; Neveen A Salem; Amany A Sleem
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

Review 2.  An update on vinpocetine: New discoveries and clinical implications.

Authors:  Yi-Shuai Zhang; Jian-Dong Li; Chen Yan
Journal:  Eur J Pharmacol       Date:  2017-11-26       Impact factor: 4.432

3.  Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats.

Authors:  Rania I Nadeem; Hebatalla I Ahmed; Bahia M El-Sayeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-18       Impact factor: 3.000

4.  Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration.

Authors:  Yujun Cai; Walter E Knight; Shujie Guo; Jian-Dong Li; Peter A Knight; Chen Yan
Journal:  J Pharmacol Exp Ther       Date:  2012-08-22       Impact factor: 4.030

5.  Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice.

Authors:  Bárbara B Colombo; Victor Fattori; Carla F S Guazelli; Tiago H Zaninelli; Thacyana T Carvalho; Camila R Ferraz; Allan J C Bussmann; Kenji W Ruiz-Miyazawa; Marcela M Baracat; Rúbia Casagrande; Waldiceu A Verri
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 6.  Vinpocetine for acute ischaemic stroke.

Authors:  D Bereczki; I Fekete
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

7.  Preconditioning with PDE1 Inhibitors and Moderate-Intensity Training Positively Affect Systemic Redox State of Rats.

Authors:  Jelena Ristic; Marko Folic; Katarina Radonjic; Milenko I Rosic; Sergey Bolevich; Omarov Israpil Alisultanovich; Nevena Draginic; Marijana Andjic; Jovana Jeremic; Isidora Milosavljevic; Vladimir Zivkovic; Vladimir Jakovljevic
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

8.  Simultaneous Alteration of the Circadian Variation of Memory, Hippocampal Synaptic Plasticity, and Metabolism in a Triple Transgenic Mouse Model of Alzheimer's Disease.

Authors:  António M Carvalho da Silva; Cristina Lemos; Henrique B Silva; Ildete L Ferreira; Angelo R Tomé; A Cristina Rego; Rodrigo A Cunha
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

Review 9.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

Authors:  Surojit Paul; Eduardo Candelario-Jalil
Journal:  Exp Neurol       Date:  2020-11-02       Impact factor: 5.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.